• Careers
  • ZOLL Patient Management Network Login
  • About Us
  • For Medical Professionals
  • LifeVest
  • Innovations in LifeVest
  • zoll-life-vest

    Innovation that delivers better outcomes

    20+ years of continuous innovation has led to a median wear time of 23.4 hours/day and zero median false alarms at 90 days.

    LifeVest Innovation Campaign Woman with blue background and green dots
    ZOLL LifeVest garment icon

    Next generation LifeVest garment

    _I2A1640

    Preferred by patients for comfort

    Patient rate the LifeVest® garment as more comfortable and easier to use, compared with the previous version1:

    • Lightweight, breathable performance wear fabrics
    • Flat seams, comfortable against the skin
    • Soft, double-plush straps

    20+ years of LifeVest design enhancements have led to a median real world Wear Time® of 23.4 hours/day.2

    “It’s comfortable. It was extremely easy. People don’t even know you’re wearing it.”

    -Tanya, LifeVest patient

    AI-enhanced algorithm icon

    AI-enhanced algorithm

    Female LifeVest patient outside with a friend

    Zero median false alarms at 90 days with advanced arrhythmia discrimination (AArD)3

    ZOLL® uses AI-based AArD technology to filter out non-physiological electrocardiogram (ECG) signals, reducing an already low rate of false alarms.

    Research published in 2023 validates LifeVest is smarter than ever.

    Clipboard icon

    20+ years of clinical evidence globally

    LifeVest is the only WCD with:

    Research from a randomised control trial combined with 20+ years of evidence make LifeVest the most studied and proven WCD.

    • 75% reduction in mortality at 90 days in patients who wore LifeVest4
    • 90% one-year survival in patients who suffered VT/VF5
    WCD coverage icon

    Patient support

    An experienced WCD support team at your side

    ZOLL has supported more than 1M LifeVest patients globally over 20+ years. Our extensive support network is here to help your patients with every step of their LifeVest journey:

    • In-person training and support
    • Representatives with extensive care experience
    • 24/7 multilingual support

    1. Data on file, 20c1184_a01. Garment Comparative Wear Test.
    2. Data on file, 90d0258_a01. 2021 Commercial Compliance Analysis.
    3. Arkles J, Delaughter C, D’Souza B. A novel artificial intelligence based algorithm to reduce wearable cardioverter-defibrillator alarms. J Interv Cardiac Electrophysiol. 2023. https://doi.org/10.1007/s10840-023-01497-w
    4. Olgin JE, Lee BK, Vittinghoff E, et al. Impact of wearable cardioverter-defibrillator compliance on outcomes in the VEST trial: As-treated and per-protocol analyses. J Cardiovasc Electrophysiol 2020;1–10.https://doi.org/10.1111/jce.14404
    5. Kutyifa V, Moss A, Klein H, et al. One-year follow-up of the prospective registry of patients using the wearable defibrillator (WEARIT-II Registry). Pacing Clin Electrophysiol. 2018;1–7. https://doi.org/10.1111/pace.13448
    6. Pre-clinical test data on file at ZOLL as of July 2020.
    7. Kutyifa V, Moss A J, Klein H, et al. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: Data from the prospective registry of patients using the wearable cardioverter defibrillator (WEARIT-II Registry). Circulation 2015;132(17):1613–1619.

    Contact a Product Expert

    ZOLL is ready to assist you in meeting your care goals. The team that has protected globally 1M+ LifeVest patients over 20+ years now provides a suite of solutions. Connect with an expert for personalised support.

    CONTACT US
    Medical professionals looking at a tablet in hospital hallway